Početna › Crohnova bolest
Kliničke studije za Crohnova bolest koje traže sudionike u SAD-u
93 studija za Crohnova bolest traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- New York City, NY35 studija
- Cleveland, OH19 studija
- St. Louis, MO19 studija
- Boston, MA19 studija
- Miami, FL19 studija
- Orlando, FL17 studija
- Houston, TX17 studija
- Atlanta, GA17 studija
- Tyler, TX16 studija
- San Diego, CA15 studija
- San Antonio, TX15 studija
- Los Angeles, CA15 studija
- Philadelphia, PA13 studija
- Colorado Springs, CO13 studija
- Durham, NC12 studija
- Providence, RI12 studija
- Tacoma, WA11 studija
- Pittsburgh, PA11 studija
- Cincinnati, OH11 studija
- Seattle, WA11 studija
- Baltimore, MD10 studija
- Washington, DC10 studija
- Indianapolis, IN10 studija
- Dallas, TX10 studija
- Lubbock, TX10 studija
- Tampa, FL10 studija
- Ann Arbor, MI9 studija
- Chicago, IL9 studija
- Louisville, KY9 studija
- Evanston, IL9 studija
- Lewisville, TX9 studija
- Rochester, MN8 studija
- Parma, OH8 studija
- New Haven, CT8 studija
- Columbus, OH8 studija
- Charlotte, NC8 studija
- Independence, MO8 studija
- Milwaukee, WI7 studija
- Lafayette, LA7 studija
- Queens, NY7 studija
Po državama
- Alabama9 studija
- Arizona17 studija
- Arkansas3 studija
- Colorado18 studija
- Connecticut14 studija
- Distrikt Columbia4 studija
- Florida27 studija
- Georgia22 studija
- Idaho4 studija
- Illinois18 studija
- Indiana13 studija
- Iowa8 studija
- Kalifornija37 studija
- Kansas11 studija
- Kentucky12 studija
- Louisiana11 studija
- Maryland15 studija
- Massachusetts27 studija
- Michigan20 studija
- Minnesota11 studija
- Mississippi3 studija
- Missouri21 studija
- Nevada8 studija
- New Hampshire3 studija
- New Jersey9 studija
- New York36 studija
- North Carolina20 studija
- Ohio30 studija
- Oklahoma8 studija
- Oregon4 studija
- Pennsylvania23 studija
- Rhode Island12 studija
- South Carolina11 studija
- South Dakota4 studija
- Tennessee10 studija
- Texas35 studija
- Utah8 studija
- Virginia15 studija
- Washington22 studija
- Wisconsin7 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
U tijeku regrutacijaOpažajna studija
Od 18 do 85 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
U tijeku regrutacijaFaza 3
Sve dobne skupine · Oba spola · Ažurirano 2. lis 2026. · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 70 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
U tijeku regrutacijaFaza 3
Od 3 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
U tijeku regrutacija
Od 16 do 75 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
U tijeku regrutacijaFaza 2
Od 18 do 85 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
U tijeku regrutacijaFaza 3
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
U tijeku regrutacijaFaza 4
Od 18 do 70 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT06045754Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.